您的购物车当前为空
别名 (S)-p38 MAPK Inhibitor III
(S)-p38 MAPK inhibitor III is a methylsulfanylimidazole that inhibits p38 MAP kinase (IC50 = 0.90 μM in vitro). It is cell-permeable, potently blocking the release of TNF-α and IL-1β from human peripheral blood mononuclear cells (IC50s = 0.37 and 0.044 μM, respectively).

(S)-p38 MAPK inhibitor III is a methylsulfanylimidazole that inhibits p38 MAP kinase (IC50 = 0.90 μM in vitro). It is cell-permeable, potently blocking the release of TNF-α and IL-1β from human peripheral blood mononuclear cells (IC50s = 0.37 and 0.044 μM, respectively).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 500 μg | ¥ 1,720 | 35日内发货 | |
| 1 mg | ¥ 3,290 | 35日内发货 | |
| 5 mg | ¥ 13,500 | 35日内发货 | |
| 10 mg | ¥ 23,600 | 35日内发货 |
| 产品描述 | (S)-p38 MAPK inhibitor III is a methylsulfanylimidazole that inhibits p38 MAP kinase (IC50 = 0.90 μM in vitro). It is cell-permeable, potently blocking the release of TNF-α and IL-1β from human peripheral blood mononuclear cells (IC50s = 0.37 and 0.044 μM, respectively). |
| 靶点活性 | p38 MAPk:0.9 μM |
| 别名 | (S)-p38 MAPK Inhibitor III |
| 分子量 | 404.5 |
| 分子式 | C23H21FN4S |
| CAS No. | 581098-48-8 |
| 密度 | 1.30 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: 12 mg/mL (29.67 mM), Sonication is recommended. Ethanol: 30 mg/mL (74.17 mM), Sonication is recommended. Ethanol:PBS (pH 7.2)(1:2): 0.33 mg/mL (0.82 mM), Sonication is recommended. DMF: 20 mg/mL (49.44 mM), Sonication is recommended. |
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1 mg/mL (2.47 mM), Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多